Rhythm Pharmaceuticals, Inc.

RYTM · Healthcare

$104.74

Capitalización: 7.21B USDRendimiento por dividendo: —
Advance¿Es buen momento para comprar Rhythm Pharmaceuticals, Inc.? Pregunta a Copenvest AIObtén una lectura Advance con IA sobre timing, riesgo y qué hacen los inversores rastreados.Preguntar a Copenvest AI

Cargando gráfico…

Noticias

Últimos titulares de esta acción

BioPharma Dive3 sept 2026, 12:20

An AI drug specialist zeroes in on rare forms of obesity

The Fly28 ago 2026, 13:38

Moderna upgraded, Allstate downgraded: Wall Street's top analyst calls

24/7 Wall St.28 ago 2026, 11:50

Here Are Friday’s Top Wall Street Analyst Research Calls: Baozun, Commerce Bancshares, Element Solutions, Evolution Petroleum, Petrobras, Rythm Pharmaceuticals, Terawulf, UMB Financial, Workday, and More

MT Newswires28 ago 2026, 11:26

Deutsche Bank Initiates Rhythm Pharmaceuticals at Hold With $120 Price Target

Simply Wall St.26 ago 2026, 10:15

Rhythm Pharmaceuticals (RYTM) Stock Looks Overvalued Despite Its 7x Five Year Run